Top Markets
Coin of the day
Qualigen Therapeutics, Inc. Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc.

QLGN
Pozycja w akcjach #35381
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing... Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for swift diagnostic testing. Its therapeutic candidates currently undergoing development include QN-302, an investigational compound targeting pancreatic ductal adenocarcinoma; QN-247, a DNA-coated gold nanoparticle formulated to combat various types of cancer; and RAS-F, a small-molecule inhibitor designed to block RAS oncogene protein-protein interactions, thereby impeding RAS mutations and suppressing tumor growth. The company is also progressing with the STARS blood cleansing system, an innovative DNA/RNA-based device engineered to purify a patient's bloodstream by eliminating tumor-derived substances and viruses. Founded in 1996, Qualigen Therapeutics, Inc. is headquartered in Carlsbad, California.
Cena akcji
$2.37
Ostatnia synchronizacja: 2025-12-15
Kapitalizacja rynkowa
$3.99M
Zmiana (1 dzień)
-5.58%
Zmiana (1 rok)
24.74%
Kraj
US
Handel Qualigen Therapeutics, Inc. (QLGN)

Kategoria

Historia ceny akcji dla Qualigen Therapeutics, Inc. (QLGN)
Najwyższa cena zamknięcia: $2.47 dnia 2025-12-01

Najniższa cena zamknięcia: $589.38K dnia 2015-06-01
Historia cen akcji firmy Qualigen Therapeutics, Inc. od 2015 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 21.69%
2025 -41.50%
2024 -86.58%
2023 -55.56%
2022 -87.61%
2021 -67.06%
2020 -20.04%
2019 -75.35%
2018 -77.36%
2017 -88.49%
2016 37.25%
2015 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE